Argent Mid Cap ETF (AMID) Chart & Stock Price History → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free AMID Stock Alerts $32.29 +0.01 (+0.03%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisChartDividendHoldingsRatingsShort InterestSocial MediaStock AnalysisChartDividendHoldingsRatingsShort InterestSocial Media Argent Mid Cap ETF Stock Price Performance5 Day Performance+1.45%1 Month Performance-5.64%3 Month Performance+6.14%6 Month Performance+32.28%Year-To-Date Performance+6.63%1 Year Performance+33.76% Receive AMID Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Argent Mid Cap ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> AMID Stock Chart for Saturday, April, 27, 2024 AMID Chart by TradingView Argent Mid Cap ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$32.28$32.29+0.03%$32.41$32.1521,901 shs$54.89 million04/25/2024$32.43$32.28-0.46%$32.28$31.961,614 shs$54.88 million04/24/2024$32.57$32.43-0.43%$32.64$32.357,472 shs$55.13 million04/23/2024$31.83$32.57+2.32%$32.57$32.511,453 shs$55.37 million04/22/2024$31.55$31.83+0.89%$32.02$31.585,638 shs$54.11 million04/19/2024$31.60$31.55-0.16%$31.58$31.457,853 shs$53.64 million Get the Latest News and Ratings for AMID and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Argent Mid Cap ETF and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$31.75$31.60-0.47%$32.25$31.604,369 shs$53.72 million04/17/2024$32.10$31.75-1.09%$32.16$31.727,526 shs$53.98 million04/16/2024$32.18$32.10-0.25%$32.15$32.103,956 shs$54.57 million04/15/2024$32.62$32.18-1.35%$32.87$32.181,930 shs$54.71 million04/12/2024$33.05$32.62-1.30%$32.83$32.622,594 shs$55.45 million04/11/2024$32.95$33.05+0.30%$33.06$32.794,913 shs$56.19 million04/10/2024$33.67$32.95-2.14%$33.66$32.942,556 shs$56.02 million04/09/2024$33.73$33.67-0.19%$33.85$33.673,340 shs$57.24 million04/08/2024$33.80$33.73-0.20%$33.78$33.731,494 shs$57.35 million04/05/2024$33.37$33.80+1.29%$33.88$33.617,269 shs$57.46 million04/04/2024$33.82$33.37-1.33%$34.32$33.371,386 shs$50.06 million04/03/2024$33.65$33.82+0.51%$33.85$33.827,956 shs$50.73 million04/02/2024$34.06$33.65-1.20%$33.65$33.416,030 shs$50.48 million04/01/2024$34.23$34.06-0.50%$34.16$34.031,236 shs$51.09 million03/29/2024$34.23$34.23$34.33$34.233,961 shs$51.35 million03/28/2024$34.22$34.23+0.03%$34.33$34.233,961 shs$51.35 million03/27/2024$33.79$34.22+1.27%$34.26$34.0616,329 shs$51.33 million03/26/2024$33.81$33.79-0.06%$33.94$33.798,855 shs$50.69 million03/25/2024$33.94$33.81-0.38%$33.95$33.8115,280 shs$50.72 million03/22/2024$34.17$33.94-0.66%$34.01$33.9215,078 shs$50.91 million03/21/2024$33.67$34.17+1.47%$34.25$34.1722,516 shs$51.25 million03/20/2024$33.34$33.67+0.99%$33.78$33.346,324 shs$50.51 million03/19/2024$32.96$33.34+1.15%$33.34$32.958,474 shs$50.01 million03/18/2024$32.88$32.96+0.24%$33.68$32.9629,129 shs$49.44 million03/15/2024$32.92$32.88-0.12%$32.98$32.881,151 shs$49.32 million03/14/2024$33.28$32.92-1.08%$33.28$32.7614,976 shs$49.38 million03/13/2024$33.29$33.28-0.03%$33.37$33.225,447 shs$49.92 million03/12/2024$32.96$33.29+1.00%$33.38$33.227,676 shs$49.94 million03/11/2024$33.35$32.96-1.17%$33.06$32.7725,202 shs$49.44 million03/08/2024$33.69$33.35-1.01%$33.82$33.3119,539 shs$50.03 million03/07/2024$33.21$33.69+1.45%$33.69$33.5712,562 shs$50.54 million03/06/2024$32.85$33.21+1.10%$33.24$33.083,601 shs$49.82 million03/05/2024$33.22$32.85-1.11%$33.11$32.852,017 shs$49.28 million03/04/2024$33.17$33.22+0.15%$33.39$33.224,299 shs$49.83 millionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>03/01/2024$32.78$33.17+1.19%$33.17$32.832,943 shs$49.76 million02/29/2024$32.56$32.78+0.68%$32.78$32.606,779 shs$49.17 million02/28/2024$32.56$32.56$32.58$32.481,903 shs$48.84 million02/27/2024$32.49$32.56+0.23%$32.56$32.122,189 shs$48.84 million02/26/2024$32.45$32.49+0.11%$32.93$32.4611,538 shs$48.73 million02/23/2024$32.29$32.45+0.50%$32.45$32.451 shs$48.68 million02/22/2024$31.77$32.29+1.64%$32.32$32.191,942 shs$48.44 million02/21/2024$31.74$31.77+0.09%$31.77$31.77117 shs$47.66 million02/20/2024$32.00$31.74-0.81%$31.77$31.632,161 shs$47.61 million02/19/2024$32.00$32.00$32.47$32.003,100 shs$48 million02/16/2024$32.17$32.00-0.53%$32.47$32.003,154 shs$48 million02/15/2024$31.81$32.17+1.13%$32.17$32.00192 shs$48.26 million02/14/2024$31.19$31.81+1.99%$31.81$31.533,551 shs$47.72 million02/13/2024$31.83$31.19-2.01%$31.38$31.19518 shs$46.79 million02/12/2024$31.69$31.83+0.44%$31.93$31.834,215 shs$47.75 million02/09/2024$31.45$31.69+0.76%$31.69$31.439,119 shs$47.54 million02/08/2024$30.94$31.45+1.63%$31.45$31.171,457 shs$47.18 million02/07/2024$30.64$30.94+1.00%$30.94$30.933,427 shs$46.42 million02/06/2024$30.51$30.64+0.42%$30.64$30.46351 shs$45.96 million02/05/2024$30.81$30.51-0.97%$30.51$30.271,897 shs$45.77 million02/02/2024$30.68$30.81+0.42%$30.81$30.81112 shs$46.22 million02/01/2024$30.25$30.68+1.42%$30.68$30.203,028 shs$46.02 million01/31/2024$30.81$30.25-1.82%$30.30$30.2111,655 shs$45.38 million01/30/2024$30.81$30.81$30.83$30.813,271 shs$46.22 million01/29/2024$30.42$30.81+1.28%$30.81$30.552,431 shs$46.22 million01/26/2024$30.47$30.42-0.16%$30.42$30.4243 shs$45.63 million Related Companies: Mid Cap US Equity Select ETF Stock Chart WisdomTree U.S. MidCap Quality Growth Fund Stock Chart First Trust Mid Cap Value AlphaDEX Fund Stock Chart First Trust Mid Cap Growth AlphaDEX Fund Stock Chart iShares Morningstar Mid-Cap Value ETF Stock Chart First Trust Mid Cap Core AlphaDEX Fund Stock Chart Receive AMID Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Argent Mid Cap ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AMID) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersYou Won't Believe Who Bezos is Working With to Fight Alzheimer'sBehind the MarketsThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Argent Mid Cap ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.